INS and type 2 diabetes mellitus: The main purpose of this study is to reliably detect hypoglycaemic events in uncontrolled type 2 diabetes patients who recently initiated treatment with basal insulin or who initiated treatment within a year prior to study enrolment, and to establish the relationship between hypoglycaemic episodes occurring during the 24‐week observational period and the achievement of glycemic target.